Our patent portfolio
A comprehensive patent portfolio
We have developed a broad patent portfolio to protect our business interests in major global market areas. We currently have 35 patents granted in the USA, Canada, Europe, China, Hong Kong, Taiwan, Japan and South Korea, and another 30+ patents are pending.
7 patent families to protect the gyrocardiography method
In total, we have seven patent families covering gyrocardiography as well as detection of atrial fibrillation, coronary artery disease, heart failure and heart attacks. If you have questions about our patents, please contact COO tuomas.valtonen@cardiosignal.com.